Skip to main content
    C

    Calidi Biotherapeutics Inc. (CLDI)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • AMEX

    $0.55
    -0.05 (-8.50%)

    Market Cap: $2.21M

    Last updated: Nov 17, 2026 at 4:24 PM ET

    Calidi Biotherapeutics Inc. (CLDI) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Calidi Biotherapeutics (CLDI) has a latest price of $0.55 on Nov 17, 2026. Its price fell 97.7% over the past 12 months. The month-end price fell 100.0% over the 3 years through Oct 2026, a compound annual decline of 94.5%.

    Price Chart

    From Nov 2021 to Oct 2026, its highest month-end close was $20,225.69 in Jul 2023 and its lowest $0.69 in Oct 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart CLDI with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for CLDI.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 60.1%, and over 6 months it fell 81.3%.

    PeriodChange
    1 month-29.7%
    3 months-60.1%
    6 months-81.3%
    12 months-97.7%
    12 months, with dividends-97.7%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-100.0%-94.5%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2022, when the price rose 3.7%, and its weakest was 2024, when it fell 92.4%.

    YearCloseChange
    2026 through Oct 2026$0.69-96.3%
    2025$18.72-91.5%
    2024$220.89-92.4%
    2023$2,900.36-85.2%
    2022$19,534.21+3.7%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 39.4% below its 50-day average of $0.91 and 84.2% below its 200-day average of $3.50.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$0.55
    50-day average$0.91-39.4%
    200-day average$3.50-84.2%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 100.0%.

    MeasureValue
    1-year beta2.55
    Largest fall, 1 year-97.8%
    Largest fall, 3 years-100.0%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About CLDI

    What is CLDI's 1-year price change?

    Calidi Biotherapeutics's price fell 97.7% over the past 12 months. With dividends included, the 12-month total return was -97.7%.

    How has CLDI stock done over the long term?

    Calidi Biotherapeutics's month-end price fell 100.0% over the 3 years through Oct 2026, a compound annual decline of 94.5%. These figures leave out dividends.

    What is CLDI's beta?

    Calidi Biotherapeutics's 1-year beta against the S&P 500 is 2.55, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 97.8%.

    Is the CLDI chart free?

    Yes. Advanced Charting for CLDI is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.